Song Chen

Song Chen has a diverse work experience starting from 2011 as a Graduate Student Researcher at Fudan University, where they designed a computer-controlling automatic sample stage system. Song then worked at the University of Maryland as a Graduate Student and Teaching Assistant from 2014 to 2017. At the National Cancer Institute (NCI), they served as a Predoctoral fellow and was responsible for designing and executing experiments with human breast cancer cells on bio-inspired nanotopographies. From 2017 to 2020, they were a Graduate Research Fellow and Teaching Assistant at the University of Michigan, focusing on elucidating mechanisms of contact guidance in cancer metastasis. In 2019, they joined miLEAD Consulting as a Consultant until 2020. Starting from 2021, Song Chen worked as a Research Fellow at the Massachusetts General Hospital, where they designed and executed in vivo experiments to understand the role of chemokine systems in guiding cytotoxic T lymphocytes to tumors and their activation during immunotherapy. Currently, they are employed as a Tumor Immunology Scientist I at Volastra Therapeutics, leading the early development of an immune-activation screen and advancing the understanding of underlying biology in chromosomal instable tumors.

Song Chen completed their Bachelor of Engineering degree in an unspecified field of study at East China University of Science and Technology from 2007 to 2011. They went on to pursue a Master of Science degree in Condensed Matter Physics at Fudan University from 2011 to 2014. Song Chen then furthered their education at the University of Maryland, where they completed their Doctor of Philosophy degree in Biophysics from 2014 to 2017. Lastly, they attended the University of Michigan to obtain another Doctor of Philosophy degree, this time in Pharmacology, from 2017 to 2020.